Pure Global

12. IMMUNOCAP TRYPTASE CONJUGATE 50 - INVIMA Registration 0b3794fd8cc650a11a93c7162884e1ab

Access comprehensive regulatory information for 12. IMMUNOCAP TRYPTASE CONJUGATE 50 (12. IMMUNOCAP TRYPTASE CONJUGATE 50) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID 0b3794fd8cc650a11a93c7162884e1ab and manufactured by PHADIA AB. The device was registered on February 22, 2031.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.

Free Database
Powered by Pure Global AI
INVIMA Official Data
II
0b3794fd8cc650a11a93c7162884e1ab
12. IMMUNOCAP TRYPTASE CONJUGATE 50
INVIMA Analysis ID: 0b3794fd8cc650a11a93c7162884e1ab
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class / Clase de Riesgo
II
Product Type (Spanish)
REACTIVO DIAGNOSTICO
Product Type (English)
DIAGNOSTIC REAGENT
Registration Information
Analysis ID
0b3794fd8cc650a11a93c7162884e1ab
Expire Date
February 22, 2031
Authorized Company / Fabricante
Name (Spanish)
PHADIA AB
Name (English)
PHADIA AB